Login
$ENVB
$1.44 -$0.07 (4.95%) Live

Ownership

13F as of Q2 2026 · 4.5M shares outstanding

Who owns ENVB?

By type of holder
Institutions 11.8% Insiders 54.7% Everyone else 33.5%
Concentration Top 10 holders own 59.7%
Tucker Joseph Edward 21.5% · Hagel Jillian Marie 12.7%
Institutional ownership
11.8%
+10.6 pts vs last qtr
Institutional holders
24
+13 vs last qtr
Net shares bought
+474.9K
by institutions in Q2 2026
New / sold out
14 / 1
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Sio Capital Management, LLC NEW +180.0K
  • Ikarian Capital, LLC NEW +100.0K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Geode Capital Management, LLC −20.4K
  • UBS Group AG −3.4K

Sign up to see all 3.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Enveric Biosciences, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2016–FY2025
−36.0%
−5.42% a year
Each share's claim on the business
+56.2%
grew without buying or selling a share
Spent on buybacks vs paid in stock
— vs $19.5M
over 9 fiscal years
Diluted shares, split-adjusted
40.7K2.9M5.8M2016: 522.7K shares'162017: 599.3K shares'172018: 951.6K shares'182019: 2.1M shares'192020: 5.8M shares'202022: 1.4M shares'222023: 143.9K shares'232024: 41.9K shares'242025: 334.7K shares'25
Buybacks Stock-based comp
$0$3.5M$7.1M2016 buybacks: $02016 stock comp: $1.5M'162017 buybacks: $02017 stock comp: $7.1M'172018 buybacks: $02018 stock comp: $1.3M'182019 buybacks: $02019 stock comp: $624.1K'192020 buybacks: $02020 stock comp: $2.0M'202022 buybacks: $02022 stock comp: $2.6M'222023 buybacks: $02023 stock comp: $2.2M'232024 buybacks: $02024 stock comp: $1.6M'242025 buybacks: $02025 stock comp: $827.3K'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years8% 1–3 years1% Under 1 year92%
Quarterly turnover
475.2%
of institutional shares changed hands
Top 10 managers, median time held
0 quarters

Super Investors

Investment managers reporting ENVB on Form 13F
SC
Sio Capital Management, LLC
Shares
180.0K
% of company
4.01%
Change vs last qtr
NEW
Held since
Q2 '26
IC
Ikarian Capital, LLC
Shares
100.0K
% of company
2.23%
Change vs last qtr
NEW
Held since
Q2 '26

23 more super investors behind a free account

See every manager holding Enveric Biosciences, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting ENVB on Form N-PORT; together they hold 1.5% of the company
AP
AdvisorShares Trust
Position value
$48.9K
% of company
0.79%
% of the fund
0.11%
As of
June 30, 2026
FE
Fidelity Concord Street Trust
Position value
$24.1K
% of company
0.39%
% of the fund
0.00%
As of
August 31, 2026

3 more funds behind a free account

See every fund holding Enveric Biosciences, Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
TJ
Tucker Joseph Edward
Insider
Shares
962.6K
% of company
21.47%
Change vs last qtr
—
Held since
—
HJ
Hagel Jillian Marie
Insider
Shares
567.4K
% of company
12.65%
Change vs last qtr
—
Held since
—

8 more holders behind a free account

See every insider and 5%+ holder of Enveric Biosciences, Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support